First Time Loading...

Vivos Therapeutics Inc
NASDAQ:VVOS

Watchlist Manager
Vivos Therapeutics Inc Logo
Vivos Therapeutics Inc
NASDAQ:VVOS
Watchlist
Price: 2.52 USD -2.7%
Updated: Apr 29, 2024

Vivos Therapeutics Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vivos Therapeutics Inc
Revenue Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Vivos Therapeutics Inc
NASDAQ:VVOS
Revenue
$13.8m
CAGR 3-Years
2%
CAGR 5-Years
29%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Revenue
$12.1B
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
0%
Quest Diagnostics Inc
NYSE:DGX
Revenue
$9.3B
CAGR 3-Years
-4%
CAGR 5-Years
4%
CAGR 10-Years
3%
CVS Health Corp
NYSE:CVS
Revenue
$357.8B
CAGR 3-Years
10%
CAGR 5-Years
13%
CAGR 10-Years
11%
Cigna Corp
NYSE:CI
Revenue
$195.3B
CAGR 3-Years
7%
CAGR 5-Years
32%
CAGR 10-Years
20%
Laboratory Corporation of America Holdings
NYSE:LH
Revenue
$12.3B
CAGR 3-Years
-7%
CAGR 5-Years
2%
CAGR 10-Years
8%

Vivos Therapeutics Inc
Revenue Breakdown

Breakdown by Geography
Vivos Therapeutics Inc

Not Available

Breakdown by Segments
Vivos Therapeutics Inc

Total Revenue: 13.8m USD
100%
Service: 7.5m USD
54.6%
Product: 6.3m USD
45.4%
Appliance Sales To Vip: 6.1m USD
44.1%
Vip: 3.9m USD
28.4%
Sleep Testing Services: 1.2m USD
8.6%
Billing Intelligence Services: 887k USD
6.4%
Myofunctional Therapy Services: 861k USD
6.2%
Sponsorship Seminar Other: 676k USD
4.9%
Center Revenue: 189k USD
1.4%
Show More
Show Less

See Also

What is Vivos Therapeutics Inc's Revenue?
Revenue
13.8m USD

Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's Revenue amounts to 13.8m USD.

What is Vivos Therapeutics Inc's Revenue growth rate?
Revenue CAGR 5Y
29%

Over the last year, the Revenue growth was -14%. The average annual Revenue growth rates for Vivos Therapeutics Inc have been 2% over the past three years , 29% over the past five years .